BBOT — BridgeBio Oncology Therapeutics
Median target
$23
calls from the last 12 months
Implied return
+370.3%
median target vs. price
Coverage
9 analysts · 11 calls
updated in the last 12 months
Consensus
9/0/0+9 net
Buy / Hold / Sell
Which analysts are behind BBOT's consensus?
See every current rating, price target and the analysts' track records for BridgeBio Oncology Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 9 analysts with calls on BBOT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.